Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].

Biomed Pharmacother

Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, PR China; Clinical College, Peking University Shenzhen Hospital, Anhui Medical University, Hefei, Anhui, 230032, PR China. Electronic address:

Published: April 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2019.108755DOI Listing

Publication Analysis

Top Keywords

corrigendum "mir-23a-3p
4
"mir-23a-3p acts
4
acts oncogene
4
oncogene potential
4
potential prognostic
4
prognostic biomarker
4
biomarker targeting
4
targeting pnrc2
4
pnrc2 rcc"
4
rcc" [biomed
4

Similar Publications

Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].

Biomed Pharmacother

April 2019

Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, PR China; Clinical College, Peking University Shenzhen Hospital, Anhui Medical University, Hefei, Anhui, 230032, PR China. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!